Tata Memorial Centre to provide affordable high-dose MIBG therapy for neuroblastoma
Mumbai: A high-dose MIBG (metaiodobenzylguanidine) therapy for treating neuroblastoma, a type of cancer mostly found in children, will be provided at an affordable cost of Rs 7-8 lakh at a research body associated with the
Tata Memorial Centre
(
TMC
).
The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), a unit of TMC at Kharghar in Navi Mumbai, treated a 17-year-old with a supra-high dose of 131I-mIBG on May 5.
Talking to reporters on Friday, TMC director Dr Sudeep Gupta said the treatment of children with high-risk neuroblastoma, which requires a multi-modality approach including anti-GD2 immunotherapy, costs around Rs 75 lakh and has a long-term cure outcome of 50 per cent.
"The anti-GD2 immunotherapy is exceptionally expensive and is not accessible to many patients in India. However, the high-dose
131I-mIBG therapy
costing Rs 7-8 lakh is affordable. With 41 'hot beds' medical isolation ward, the largest in the world, the TMC plans to routinely provide this treatment to eligible patients with high-risk neuroblastoma," he said.
Even the toilet and wash water from the room are piped to a sealed "delay-decay" tank so the radioactivity can fade before the wastewater is released into the regular sewer system.
Live Events
This is the first high-dose 131I-mIBG therapy administered in India with a 25-35 per cent long-term cure outcome, where the patient was administered 800 mCI of 131I-mIBG.
In India, the standard dose of 131I-mIBG is 5 millicuries per kilogram (maximum 300 mCI).
"The previous highest total dose of 131I-mIBG in a single setting in India has been 300 mCI. Specialists from the departments of nuclear medicine, paediatric oncology, haematological oncology (bone marrow transplant) and transfusion medicine were involved in the planning and execution of this complex treatment," Dr Gupta said.
For the higher dose, the Atomic Energy Regulatory Board (AERB) gave its approval after the TMC submitted a report from a simulation experiment at the premises, addressing issues such as isolation protocols, radiation safety concerns, dosimetry calculations, patient monitoring and management of emergency crises.
He said this treatment requires coordination of doctors, physicists, technical staff, nurses and auxiliary staff from the departments of nuclear medicine, paediatric and haematological oncology (bone marrow transplant unit) and transfusion medicine, and the Board of Radiation and Isotope Technology (BRIT).
In India, 1,500 children are detected with neuroblastoma annually, Dr Gupta added. PTI
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Naidu govt disburses Rs 400 crore under CMRF in last one year
Vijayawada: Chief minister N Chandrababu Naidu proved to be generous compared to other chief ministers in giving out aid to needy people from the Chief Minister's Relief Fund (CMRF). In the last year alone, after becoming the chief minister for the fourth time, Naidu gave out Rs 400 crore, which is nearly half the amount spent under CMRF between 2019 and 2024. The CMRF is intended to help those who were hit with unexpected health crisis and had to spend huge amounts on treatment in private hospitals. Though a large number of procedures are covered under NTR Vaidya Seva, those who are not eligible for the scheme and in cases where people spend huge amounts on specialised treatments not covered in the scheme, people often find themselves in helpless situations. The CMRF is coming to the rescue of those persons, and Naidu surpassed all four chief ministers in terms of assistance provided. Between 2014 and 2019, an amount of Rs 1,533 crore was disbursed to 2,23,742 families. This is more than double the amount spent by three chief ministers between 2004 and 2014 in combined Andhra Pradesh. During the ten-year period in united Andhra Pradesh with 23 districts, including Telangana, the total amount disbursed under CMRF was only Rs 758 crore. Even during the YSRCP regime between 2019 and 2024, the total amount spent under CMRF was only Rs 897 crore for five years, which is only half of what Naidu gave during his previous term. Naidu reached the halfway mark of what was spent in the last five years in just one year by giving aid to 35,000 families. For as many as 3,354 people with medical emergencies, a letter of credit (LoC) was issued to ensure timely treatment. Based on the family's financial condition and the seriousness of the illness, amounts ranging from Rs 50,000 to Rs 30 lakh were disbursed.
Time of India
an hour ago
- Time of India
Maval MP raises issue of denial of Ayushman Bharat benefits by hospitals with Nadda
1 2 Pune: Shiv Sena MP from Maval Shrirang Barne has raised the issue of hospitals denying treatment under the Centre's Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (PM-JAY) with Union health minister J P Nadda . During his visit to Delhi on Wednesday, Barne met Nadda and submitted complaints received from citizens who were allegedly refused treatment despite being eligible under the centrally-sponsored health assurance scheme. He informed the minister that although 148 hospitals in Pune district were currently empanelled under the Ayushman Bharat scheme, several of them have been turning away patients, undermining the core objective of the scheme launched in 2018. Though the issue had been raised multiple times with the local authorities, the MP decided to take it up directly with the Union health minister as the problem persisted across several regions. You Can Also Check: Pune AQI | Weather in Pune | Bank Holidays in Pune | Public Holidays in Pune The MP said that Nadda took immediate cognizance of the matter and directed his secretary to look into the complaints and take suitable action. "The minister has also assured that strict action will be taken against hospitals denying treatment to eligible patients under the scheme," Barne added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo The objective of the scheme is to provide quality and free healthcare services to poor and needy citizens. Last year, the govt also approved inclusion of all senior citizens above the age of 70 under the scheme. The scheme provides health coverage of up to Rs 5 lakh per family per year for secondary and tertiary care hospitalisation, benefiting many from economically weaker citizens across the country. Barne said that denial of treatment not only violated the directives of the central govt but also infringed upon the health rights of senior citizens. As a result, many elderly people in Pune district were unable to access timely and adequate medical care, putting their lives at risk. "Strict legal action should be taken against hospitals not implementing the scheme. Immediate instructions must be issued to all empanelled hospitals in Pune district to mandatorily implement the scheme. Additionally, a monitoring mechanism should be established to ensure that senior citizens receive treatment under this scheme in a smooth and hassle-free manner," he said.
Time of India
2 hours ago
- Time of India
India's highest radiation dose used at Tata hosp, may slash kid cancer treatment cost
Mumbai: The treatment chamber's walls had to be lead-shielded, the next few rooms vacated and several other strict safety measures put in place before two highly radioactive injections were given at a gap of just 15 seconds to a 17-year-old with stage 4 neuroblastoma at the Tata Memorial Centre's ACTREC facility in Kharghar recently. It marked the first time such a high-radiation dose procedure had been attempted in India, requiring extensive planning over three months, multiple safety checks, and full-scale mock drills, reports Eshan Kalyanikar. Treatment for neuroblastoma, a type of cancer mostly associated with children, will change significantly and could be provided for Rs 4-5 lakh. At the moment, treating a high-risk neuroblastoma requires a multi-modality approach, including anti-GD2 immunotherapy, and costs could go up to Rs 75 lakh, said oncologists. The patient was treated on May 5 and discharged in 5 days. This week, he was considered out of danger — for now. The outcome of the treatment will be determined over the next two years depending on if the patient has cured or had a relapse. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai We were coordinating with Sloan Kettering Cancer Center in New York. There were three meetings with them, as they have performed over 100 such procedures before. Our confidence increased after learning that our hospital was already extensively equipped," said Dr Archi Agrawal, head of the nuclear medicine department who spearheaded the pioneering treatment and was one of the two doctors who administered the injections. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 15 Most Gorgeous Women, Ranked BigGlobalTravel Undo A patient remains highly radioactive after the therapy and even bodily fluids and excretions pose a risk of nuclear exposure to others. To prevent this, urine and stool were collected and stored in special containment systems — 'delay-decay tanks' — designed to hold radioactive waste for several days until the radiation decays to safe levels before disposal. From lead-shielded walls and a high-isolation treatment room to a long-term nuclear biomedical waste holding system, doctors said the procedure was only possible because the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) had much of the required infrastructure in place. The treatment, called 131I-mIBG, is a type of radiotherapy in which a radioactive form of iodine is attached to a molecule (MIBG) that is absorbed by neuroblastoma cells. This allows targeted radiation to the tumor while sparing most healthy tissues. "Until now, only a 300-millicurie dose of this therapy was administered to patients," said TMC director Sudeep Gupta. Most hospitals typically administer 200 millicuries. "We aimed to deliver 800 millicuries: four times the usual dose and the highest ever given in India," said Dr Venkatesh Rangarajan from the department of nuclear medicine. The permissions had to be obtained from the Atomic Energy Regulatory Board (AERB). The hospital recalled that two AERB officials were sent to ACTREC to monitor the procedure. Dr Agarwal emphasised that there was no room for error and that the safety of the patient and everyone in the hospital was the top priority. "We managed it because the patient and their family were highly cooperative, and isolation protocols were strictly followed. Everything, from food to medical assessments, had to be managed through the door, from a distance," she said, adding that she would have risked radiation exposure herself to rush to the patient had he experienced an emergency hypertensive episode. "That was a risk, but thankfully, it did not occur," she said. Other departments involved include departments of paediatric oncology, the bone marrow transplant unit, and the transfusion medicine department. Dr Navin Khatry of haematology department said that the cure rate for this treatment is 30%, with a relapse typically occurring within two to three years. He added, "The condition impacts paediatric patients. This treatment will be only given to patients who have had a relapse. We will be doing clinical trials before moving ahead with this therapy for others." No Mixed-Media Items
